E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinib
Akihiko Miyanaga(Nippon Medical School), Shoji Kudoh(Nippon Medical School)
Cited by 17
Related Papers
Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)
|British Journal of Cancer|2005|135
PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors
|International Journal of Oncology|2007|53